Published in Circulation on September 08, 1998
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care (2010) 2.43
LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment. Eur J Nucl Med Mol Imaging (2012) 1.40
Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol (2012) 1.36
Autonomic aspects of arrhythmogenesis: the enduring and the new. Curr Opin Cardiol (2004) 1.35
Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes (2014) 1.19
What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res (2012) 1.17
Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes (2015) 1.08
Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry (2005) 1.05
Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus. Heart Vessels (2007) 1.02
Role of PET in the evaluation and understanding of coronary physiology. J Nucl Cardiol (2007) 1.02
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol (2008) 1.00
Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions. Curr Cardiol Rev (2012) 0.98
Heterogeneous ventricular sympathetic innervation, altered beta-adrenergic receptor expression, and rhythm instability in mice lacking the p75 neurotrophin receptor. Am J Physiol Heart Circ Physiol (2010) 0.96
Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol (2013) 0.94
Abnormal left ventricular torsion and cardiac autonomic dysfunction in subjects with type 1 diabetes mellitus. Metabolism (2011) 0.93
Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences. J Diabetes Res (2017) 0.88
Effect of diabetes on serum potassium concentrations in acute coronary syndromes. Heart (2003) 0.88
Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia (2013) 0.86
Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging (2007) 0.81
Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density. J Nucl Med (2006) 0.79
The management of diabetic neuropathy in CKD. Am J Kidney Dis (2009) 0.79
Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography. Eur J Nucl Med Mol Imaging (2006) 0.78
Screening of autonomic neuropathy in patients with type 2 diabetes. Diabetes Metab J (2014) 0.78
Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions. J Nucl Cardiol (2012) 0.78
Morphology of human intracardiac nerves: an electron microscope study. J Anat (2000) 0.77
Molecular imaging in heart failure patients. Clin Transl Imaging (2013) 0.75
Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes. Heart (2004) 0.75
Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart Int (2014) 0.75
Quantification of [(11)C]-meta-hydroxyephedrine uptake in human myocardium. EJNMMI Res (2014) 0.75
Effects of metabolic and myocardial microcirculatory abnormalities on the pathogenesis of cardiac autonomic neuropathy in type 2 diabetes mellitus: A prospective study in Japanese patients. Curr Ther Res Clin Exp (2005) 0.75
Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods. Nucl Med Commun (2017) 0.75
Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results. Heart Int (2014) 0.75
Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake. Eur J Nucl Med Mol Imaging (2006) 0.75
Left ventricular metabolism, function, and sympathetic innervation in men and women with type 1 diabetes. J Nucl Cardiol (2016) 0.75
Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med (2001) 3.39
Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med (1999) 3.20
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res (2001) 3.01
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol (1994) 2.78
Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med (1986) 2.63
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol (2000) 2.58
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol (2000) 2.28
Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol (1992) 2.18
Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med (1991) 2.18
Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation (2009) 2.15
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med (2001) 2.12
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med (1999) 2.11
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol (1990) 2.07
Insulin secretion in diabetes mellitus. Am J Med (1981) 2.05
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med (2001) 2.00
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology (2009) 1.99
beta-Methyl-15-p-iodophenylpentadecanoic acid metabolism and kinetics in the isolated rat heart. Eur J Nucl Med (1989) 1.96
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med (1995) 1.95
Scintigraphic localization of pheochromocytoma. N Engl J Med (1981) 1.88
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol (1999) 1.86
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain (2001) 1.83
Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation (1990) 1.78
Resting coronary flow and coronary flow reserve in human infants after repair or palliation of congenital heart defects as measured by positron emission tomography. J Thorac Cardiovasc Surg (1998) 1.73
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol (1990) 1.73
Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes (1982) 1.69
The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol (1992) 1.68
Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol (1997) 1.68
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med (1999) 1.63
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med (1980) 1.62
Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med (1997) 1.61
Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A (2009) 1.60
The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes. Diabetes (1982) 1.59
Body fat and the activity of the autonomic nervous system. N Engl J Med (1988) 1.58
Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1989) 1.51
Three-dimensional imaging of microstructure in Au nanocrystals. Phys Rev Lett (2003) 1.50
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med (2000) 1.48
Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care (1984) 1.48
Iodine-125-MIBG to treat neuroblastoma: preliminary report. J Nucl Med (1990) 1.48
Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol (1991) 1.48
Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography. Eur Heart J (2001) 1.47
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging (2007) 1.46
Reconstruction of the shapes of gold nanocrystals using coherent x-ray diffraction. Phys Rev Lett (2001) 1.46
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol (1991) 1.45
Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Eur J Nucl Med (2000) 1.45
Region-specific encoding of sensory and affective components of pain in the human brain: a positron emission tomography correlation analysis. Ann Neurol (1999) 1.43
Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus: a PET study with [18F]deoxyglucose. ORL J Otorhinolaryngol Relat Spec (1997) 1.42
Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress. J Nucl Med (1992) 1.41
Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium. J Am Coll Cardiol (1992) 1.41
An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med (1993) 1.39
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging (2006) 1.39
Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. J Am Coll Cardiol (1999) 1.38
Characterization of translocation contact sites involved in the import of mitochondrial proteins. J Cell Biol (1987) 1.37
Differential changes of autonomic nervous system function with age in man. Am J Med (1983) 1.36
Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med (1993) 1.36
Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology (2005) 1.33
Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging (2012) 1.33
A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation (1992) 1.32
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood (1998) 1.32
Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med (1981) 1.31
Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med (1989) 1.30
Carbon-11-acetate PET imaging in renal disease. J Nucl Med (1995) 1.28
Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr (1995) 1.26
Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression. Nuklearmedizin (2004) 1.25
Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation (2000) 1.22
Inter-crystal scatter in a dual layer, high resolution LSO-APD positron emission tomograph. Phys Med Biol (2003) 1.22
Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med (1981) 1.21
Dual-[11C]tracer single-acquisition positron emission tomography studies. J Cereb Blood Flow Metab (2001) 1.20
Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation (2000) 1.20
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst (1996) 1.19
Breast imaging with fluorine-18-FDG PET: quantitative image analysis. J Nucl Med (1997) 1.18
Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation (1994) 1.18
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med (1987) 1.18
Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol (1991) 1.17
Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain (2001) 1.16
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med (2001) 1.16
Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol (1984) 1.15
Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med (1999) 1.14
Myocardial blood flow and flow reserve after coronary reimplantation in patients after arterial switch and ross operation. Circulation (2001) 1.13
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol (1996) 1.13
NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA. J Biol Chem (2001) 1.12
Compartmental analysis of technetium-99m-teboroxime kinetics employing fast dynamic SPECT at rest and stress. J Nucl Med (1994) 1.12
Quantitative evaluation of sympathetic and parasympathetic control of iris function. Diabetes Care (1984) 1.11
PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging (2002) 1.10
Metabolic fate of [13N]ammonia in human and canine blood. J Nucl Med (1990) 1.09
Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb Med (1997) 1.08
Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med (1990) 1.07
Patterns of left ventricular dilation during the six months after myocardial infarction. J Am Coll Cardiol (1989) 1.07
Radionuclide angiographic evaluation of ventricular function in isolated congenitally corrected transposition of the great arteries. Am J Cardiol (1986) 1.07
Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care (1984) 1.07
Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation (1994) 1.06
Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1987) 1.06